- Home
- APWC vs COEP Comparison
APWC vs COEP Comparison
Compare APWC & COEP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APWC
- COEP
- Stock Information
- Founded
- APWC 1996
- COEP 2017
- Country
- APWC Taiwan
- COEP United States
- Employees
- APWC N/A
- COEP N/A
- Industry
- APWC Telecommunications Equipment
- COEP Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- APWC Industrials
- COEP Health Care
- Exchange
- APWC Nasdaq
- COEP Nasdaq
- Market Cap
- APWC 30.1M
- COEP 30.5M
- IPO Year
- APWC 1997
- COEP N/A
- Fundamental
- Price
- APWC $1.62
- COEP $7.70
- Analyst Decision
- APWC
- COEP
- Analyst Count
- APWC 0
- COEP 0
- Target Price
- APWC N/A
- COEP N/A
- AVG Volume (30 Days)
- APWC 3.7K
- COEP 62.5K
- Earning Date
- APWC 03-31-2025
- COEP 05-09-2025
- Dividend Yield
- APWC N/A
- COEP N/A
- EPS Growth
- APWC N/A
- COEP N/A
- EPS
- APWC 0.17
- COEP N/A
- Revenue
- APWC $472,672,000.00
- COEP N/A
- Revenue This Year
- APWC N/A
- COEP N/A
- Revenue Next Year
- APWC N/A
- COEP N/A
- P/E Ratio
- APWC $9.17
- COEP N/A
- Revenue Growth
- APWC 11.02
- COEP N/A
- 52 Week Low
- APWC $1.24
- COEP $2.31
- 52 Week High
- APWC $2.02
- COEP $13.70
- Technical
- Relative Strength Index (RSI)
- APWC 54.52
- COEP 36.79
- Support Level
- APWC $1.55
- COEP $9.16
- Resistance Level
- APWC $1.65
- COEP $12.50
- Average True Range (ATR)
- APWC 0.08
- COEP 0.84
- MACD
- APWC 0.01
- COEP 0.08
- Stochastic Oscillator
- APWC 75.00
- COEP 22.33
About APWC Asia Pacific Wire & Cable Corporation Ltd. (Bermuda)
Asia Pacific Wire & Cable Corp Ltd is a holding company. It is principally engaged in owning operating companies engaged in the power cable, telecommunication cable, enameled wire, and electronic cable industry. It also provides project engineering services to customers. Some of the company's products are Bare wires, Power cables, Communication cables, Electronic wires & cables, and Enamelled wires. The company's geographical segments are North Asia, Thailand, and Rest of the World.
About COEP Coeptis Therapeutics Holdings Inc.
Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.